QIAGEN N.V. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.91 USD | -0.16% |
|
+1.77% | -3.85% |
| May. 02 | QIAGEN Announces the Availability of QCI Secondary Analysis | CI |
| Apr. 30 | QIAGEN NV : Berenberg reaffirms its Buy rating | ZD |
Chart calendar Qiagen N.V.
54c753055c3ee32fa3dc1.lO2BrKHhMijcCq8yi20FJShjLR67us0F2fuWetorG90.86To4ZCkX0eaQc566jtQVGsWZHDu_4ZHvK3fS71sUejivuLEk4lmW-Q7wA~29207c427080d4daef30c2e7357952d1
Upcoming events on Qiagen N.V.
Past events on Qiagen N.V.
| 2024-04-30 09:00 am | Q1 2024 Earnings Call |
| 2024-04-29 04:05 pm | Q1 2024 Earnings Release |
| 2024-04-04 | American Association for Cancer Research Meeting |
| 2024-03-26 09:00 am | BNP Exane Healthcare Conference |
| 2024-03-05 02:10 pm | TD Cowen Health Care Conference |
| 2024-02-27 03:00 am | UBS European Healthcare Conference |
| 2024-02-26 03:00 am | Morgan Stanley European MedTech and Life Sciences Conference |
| 2024-02-07 09:00 am | Q4 2023 Earnings Call |
| 2024-02-06 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-29 | Reverse Split: 24.25 of 25 |
| 2024-01-29 | Capital return instalment |
| 2024-01-15 10:00 am | German Corporate Conference |
| 2024-01-12 03:00 am | ODDO BHF Forum |
| 2024-01-09 09:00 am | Commerzbank and ODDO BHF German Investment Conference |
| 2024-01-08 04:30 pm | JPMorgan Healthcare Conference |
| 2023-12-11 | Virtual DILS CEO Exane Conference |
| 2023-11-28 12:30 pm | Evercore ISI Healthcare Conference |
| 2023-11-21 | Kepler Cheuvreux Digital Diagnostics Day |
| 2023-10-31 09:00 am | Q3 2023 Earnings Call |
| 2023-10-30 04:05 pm | Q3 2023 Earnings Release |
Past dividends on Qiagen N.V.
| 2024-01-29 | 1.28 USD |
| 2017-01-24 | 1.04 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 526 1 526 0.06% | 1 870 1 858 0.68% | 2 252 2 198 2.44% | 2 142 2 139 0.12% | 1 965 1 960 0.26% | 2 008 |
|
EBITDA Million USD | Released Forecast Spread | 552 532 3.7% | 748 723 3.4% | 884 870 1.67% | 790 791 -0.14% | 659 675 -2.34% | 719 |
|
EBIT Million USD | Released Forecast Spread | 422 412 2.5% | 627 623 0.57% | 755 714 5.73% | 656 654 0.33% | 529 524 0.88% | 564 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -77,8 -77,9 0.13% | 439 364 20.66% | 626 564 11.04% | 513 538 -4.72% | 430 437 -1.7% | 519 |
|
Net income Million USD | Released Forecast Spread | -41,5 -29,5 -40.57% | 359 294 22.31% | 513 475 7.83% | 423 424 -0.14% | 341 344 -0.65% | 404 |
|
EPS USD | Released Forecast Spread | -0,19 -0,11 -62.85% | 1,58 1,30 20.88% | 2,28 2,17 4.8% | 1,90 1,96 -2.99% | 1,48 1,54 -3.96% | 1,82 |
| Announcement Date | 04/02/20 | 09/02/21 | 08/02/22 | 10/02/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 628 591 6.36% | 516 500 3.15% | 500 482 3.71% | 498 486 2.55% | 485 479 1.41% | 495 493 0.38% | 476 471 1.07% | 509 504 1.01% | 459 457 0.41% | 496 | 506 | 538 | 489 | 525 |
|
EBITDA Million USD | Released Forecast Spread | 266 240 11.11% | 179 165 8.14% | 176 158 11.2% | 169 164 2.57% | 158 163 -3.31% | 168 194 -13.27% | 158 149 5.95% | 175 175 -0.02% | 153 150 1.93% | 171 | 180 | 197 | 166 | 180 |
|
EBIT Million USD | Released Forecast Spread | 232 205 13.24% | 146 133 10.33% | 144 129 11.06% | 135 128 5.61% | 124 123 0.65% | 136 134 1.4% | 126 127 -0.37% | 142 139 2.34% | 118 117 0.49% | 135 | 144 | 160 | 130 | 147 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 95,7 94,5 1.29% | |||||||||||||
|
Net income Million USD | Released Forecast Spread | 155 138 12.44% | 96,7 78,2 23.67% | 82,4 78,1 5.44% | 88,8 73,7 20.58% | 85,0 75,1 13.24% | 80,8 86,1 -6.2% | 77,8 84,7 -8.14% | 97,7 92,3 5.76% | 80,7 76,3 5.79% | 103 | 108 | 120 | 97,6 | 114 |
|
EPS USD | Released Forecast Spread | 0,69 0,62 12.09% | 0,43 0,36 21.29% | 0,37 0,35 6.42% | 0,40 | 0,38 0,33 14.04% | 0,36 0,37 -2.98% | 0,35 0,38 -8.76% | 0,42 0,41 3.43% | 0,36 0,34 6.88% | 0,46 | 0,48 | 0,53 | 0,44 | 0,51 |
| Announcement Date | 27/04/22 | 26/07/22 | 07/11/22 | 10/02/23 | 03/05/23 | 08/08/23 | 30/10/23 | 06/02/24 | 29/04/24 | - | - | - | - | - |
| 2024-05-06 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-06 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-07 01:00 am | VALNEVA: Q1 2024 Earnings Release |
| 2024-05-07 07:00 am | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Qiagen N.V.
| 2024-05-02 04:10 pm | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:05 pm | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 04:01 pm | GALAPAGOS NV: Q1 2024 Earnings Release |
| 2024-05-02 08:00 am | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:05 am | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-02 07:00 am | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 2024-05-02 06:30 am | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QGEN Stock
- Calendar Qiagen N.V.